ENBUCRILATE: 88 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
88
Total FAERS Reports
8 (9.1%)
Deaths Reported
11
Hospitalizations
88
As Primary/Secondary Suspect
3
Life-Threatening
2
Disabilities
First Report: 2011 · Latest Report: 20240901
What Are the Most Common ENBUCRILATE Side Effects?
#1 Most Reported
Product use in unapproved indication
36 reports (40.9%)
#2 Most Reported
Device dislocation
11 reports (12.5%)
#3 Most Reported
Splenic infarction
6 reports (6.8%)
All ENBUCRILATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Product use in unapproved indication | 36 | 40.9% | 5 | 4 |
| Device dislocation | 11 | 12.5% | 0 | 1 |
| Off label use | 6 | 6.8% | 0 | 1 |
| Splenic infarction | 6 | 6.8% | 0 | 1 |
Who Reports ENBUCRILATE Side Effects? Age & Gender Data
Gender: 47.7% female, 52.3% male. Average age: 53.6 years. Most reports from: JP. View detailed demographics →
Is ENBUCRILATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 1 | 0 |
| 2016 | 1 | 0 | 0 |
| 2017 | 1 | 1 | 0 |
| 2019 | 2 | 1 | 0 |
| 2020 | 2 | 0 | 0 |
| 2022 | 1 | 0 | 0 |
| 2024 | 6 | 0 | 0 |
What Is ENBUCRILATE Used For?
| Indication | Reports |
|---|---|
| Therapeutic embolisation | 61 |
| Sclerotherapy | 9 |
Official FDA Label for ENBUCRILATE
Official prescribing information from the FDA-approved drug label.